James J. /ky Obrien

James J. /ky Obrien (board member) discloses dealings in 5 companies, chiefly Ashland Inc., Albemarle Corp and Humana Inc. The record holds 83 filings, for trades running from 28 March 2006 to 2 September 2026.

Market trades split into 13 purchases (€958k) and 16 sales (€42.9M). Taken together, the sales exceed the purchases by €42.0M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 33 share grants and 11 option exercises.

In size, the median ticket on the buying side is €14k. Looking at 13 purchases old enough to measure, the stock rose over the following 90 days in 46% of cases; the median change was -2.4%. These figures describe past trades and do not predict future prices.

On 3 September 2026 came the latest disclosure, a transaction in Eastman Chemical Co. The last purchase on record was published on 28 August 2025, which is 424 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.